Nav: Home

CSU to provide bioprocessing expertise for Department of Defense

December 05, 2016

FORT COLLINS, COLORADO - Facilities that manufacture biologic drugs like vaccines are a critical part of the nation's biodefense infrastructure. Possible breaches of data systems controlling these biomanufacturing supply chains call for an assessment of their vulnerability to cyberattacks.

Colorado State University's Jean Peccoud, professor in the Department of Chemical and Biological Engineering and the Abell Endowed Chair in Synthetic Biology, is part of a multi-institutional team newly commissioned to analyze the security of the nation's biomanufacturing infrastructure. Peccoud brings an extensive research background to the team, as well as experience training government agencies in analyzing the vulnerabilities of biotechnology supply chains.

The U.S. Department of Defense has awarded a contract to the National Strategic Research Institute (NSRI) at the University of Nebraska to lead the research project in cyberbiosecurity, engaging a team of scientists that includes Peccoud, along with researchers at the University of Nebraska-Lincoln, Virginia Tech and U.S. Strategic Command. Their aim is to provide specific recommendations to the Department of Defense for strengthening biomanufacturing infrastructure.

The NSRI is one of 13 University Affiliated Research Centers across the nation, charged with delivering research solutions for the Department of Defense in areas affecting national security.

The Biological Process Development Facility at University of Nebraska-Lincoln will serve as the proof-of-concept centerpiece facility for the project. Peccoud, an expert in bioinformatics, will work with the facility to analyze best practices and perform a security risk assessment.

"If every computer system is theoretically vulnerable to cyberattacks, how might these vulnerabilities impact the safety, delays, and production of biomanufacturing processes?" Peccoud said. "We need to ensure the integrity of the flow of physical material and the flow of data associated with biomanufacturing processes."

"Our project will set the foundations of cyberbiosecurity as a new specialty at the interface between biosecurity and cybersecurity," said project principal investigator Randall Murch, associate director for research program development at Virginia Tech.

Wally Buchholz, director of the University of Nebraska's bioprocessing facility, says: "This project will identify all critical information that is essential to a bioproduction facility's successful operation and outcome. The results will help us to understand the tolerances and vulnerabilities that can be exploited for various nefarious purposes and the specific methods that could be used."

CSU is also an integral part of the national biodefense system. BioMARC, the university's high-containment biomanufacturing unit develops, manufactures and tests vaccines for the Department of Defense and other government agencies.

Colorado State University

Related Vaccines Articles:

Better vaccines are in our blood
Red blood cells don't just shuttle oxygen from our lungs to our organs: they also help the body fight off infections by capturing pathogens in the blood and presenting them to immune cells in the spleen.
Challenges in evaluating SARS-CoV-2 vaccines
With more than 140 SARS-CoV-2 vaccines in development, the race is on for a successful candidate to help prevent COVID-19.
Designing vaccines from artificial proteins
EPFL scientists have developed a new computational approach to create artificial proteins, which showed promising results in vivo as functional vaccines.
Misinformation on vaccines readily available online
Parents researching childhood vaccinations online are likely to encounter significant levels of negative information, researchers at the University of Otago, Wellington, have found.
Battle with the cancer: New avenues from childhood vaccines
A new research from the University of Helsinki showed for the first time how the pre-immunization acquired through common childhood vaccines can be used to enhance therapeutic cancer treatment.
Personalized cancer vaccines
The only therapeutic cancer vaccine available on the market has so far showed very limited efficacy in clinical trials.
Doubts raised about effectiveness of HPV vaccines
A new analysis of the clinical trials of HPV vaccines to prevent cervical cancer raises doubts about the vaccines' effectiveness.
Egg-based flu vaccines: Not all they're cracked up to be?
Flu season is underway in the Northern Hemisphere, sickening millions of people and in rare cases, causing hospitalization or death.
You're probably not allergic to vaccines
Five facts about allergies to vaccines, pulled together by two McMaster University physicians.
Micromotors deliver oral vaccines
Vaccines have saved millions of lives, but nobody likes getting a shot.
More Vaccines News and Vaccines Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Listen Again: The Power Of Spaces
How do spaces shape the human experience? In what ways do our rooms, homes, and buildings give us meaning and purpose? This hour, TED speakers explore the power of the spaces we make and inhabit. Guests include architect Michael Murphy, musician David Byrne, artist Es Devlin, and architect Siamak Hariri.
Now Playing: Science for the People

#576 Science Communication in Creative Places
When you think of science communication, you might think of TED talks or museum talks or video talks, or... people giving lectures. It's a lot of people talking. But there's more to sci comm than that. This week host Bethany Brookshire talks to three people who have looked at science communication in places you might not expect it. We'll speak with Mauna Dasari, a graduate student at Notre Dame, about making mammals into a March Madness match. We'll talk with Sarah Garner, director of the Pathologists Assistant Program at Tulane University School of Medicine, who takes pathology instruction out of...
Now Playing: Radiolab

What If?
There's plenty of speculation about what Donald Trump might do in the wake of the election. Would he dispute the results if he loses? Would he simply refuse to leave office, or even try to use the military to maintain control? Last summer, Rosa Brooks got together a team of experts and political operatives from both sides of the aisle to ask a slightly different question. Rather than arguing about whether he'd do those things, they dug into what exactly would happen if he did. Part war game part choose your own adventure, Rosa's Transition Integrity Project doesn't give us any predictions, and it isn't a referendum on Trump. Instead, it's a deeply illuminating stress test on our laws, our institutions, and on the commitment to democracy written into the constitution. This episode was reported by Bethel Habte, with help from Tracie Hunte, and produced by Bethel Habte. Jeremy Bloom provided original music. Support Radiolab by becoming a member today at     You can read The Transition Integrity Project's report here.